Literature DB >> 24855112

Association of chylothorax and direct pleura involvement in a case of Waldenström's macroglobulinaemia.

Johanne Poisson1, Amelie Aregui1, Luc Darnige2, Karin Maley1, Mathilde Gisselbrecht1.   

Abstract

An 82-year-old male was hospitalised for dyspnoea, hypoxaemia and general fatigue; a predominant left chylothorax was revealed. Previously, he had been diagnosed with Waldenström's macroglobulinaemia (WM). Chylothorax complications in patients with WM are rare events and only six such cases have so far been reported. The most common malignant causes of chylothorax are through mediastinal adenopathy. Direct infiltration of the pleura by tumour cells is the most likely cause with this patient, and for this reason, we believe that this case is an instructive one. Chemotherapy induced rapid and persistent improvement after 10-month follow-up.
© The Author 2014. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Waldenström's macroglobulinaemia; chylothorax; lymphoplasmacytic cells; older people; pleura involvement

Mesh:

Year:  2014        PMID: 24855112     DOI: 10.1093/ageing/afu061

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  3 in total

1.  Chylothorax as an Initial Manifestation of Waldenström macroglobulinemia.

Authors:  Natalia Rodriguez Botero; Andres Zerrate Misas; Kenny Mauricio Galvez Cardenas; Juan David Ramirez Quintero
Journal:  Cureus       Date:  2020-04-06

2.  A rare clinical presentation of Waldenström Macroglobulinemia mimicking lung cancer.

Authors:  Michael Rt Laursen; Shailesh Kolekar; Pradeesh Sivapalan; Paul F Clementsen; Uffe Bodtger
Journal:  Respir Med Case Rep       Date:  2022-01-05

3.  Recurrent chylothorax: a clinical mystery.

Authors:  Eva Otoupalova; Shaiva Ginoya Meka; Sanjay Dogra; Bhavin Dalal
Journal:  BMJ Case Rep       Date:  2017-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.